AKT1 and non-small cell lung carcinoma: BEZ235 downregulated cyclin D1 and cyclin D3 expression in NSCLC through transcriptional repression and proteasome-mediated degradation, ultimately arresting the cell cycle at the G1 phase and inhibiting PI3K/Akt activity [203].